US Patent Issued to BREXOGEN on Dec. 2 for "Precursor cells of induced pluripotent stem cell (IPSC)-derived mesenchymal stem cells and method for preparing the same" (South Korean Inventor)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,493, issued on Dec. 2, was assigned to BREXOGEN INC. (Seoul, South Korea).

"Precursor cells of induced pluripotent stem cell (IPSC)-derived mesenchymal stem cells and method for preparing the same" was invented by Sue Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells and a preparation method therefor. The precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells of the present disclosure have enhanced functionality and excellent proliferative capacity compared with typical mesenchymal stem cells ...